Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)
Public ClinicalTrials.gov record NCT00747227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Evaluation of a Modified Light Transmission IOL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).
Study identification
- NCT ID
- NCT00747227
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- Nov 11, 2011
2006 – 2009
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Patrick Aiello, M.D. | Scottsdale | Arizona | 85054 | — |
| Randall E. Cole, M.D. | Rogers | Arkansas | 72756 | — |
| Aron Rose, M.D. | New Haven | Connecticut | 06510 | — |
| Y. Ralph Chu, M.D. | Bloomington | Minnesota | 55420 | — |
| Steven Silverstein, M.D. | Kansas City | Missouri | 64133 | — |
| Jon-Marc Weston, M.D. | Roseburg | Oregon | 97470 | — |
| William Christie, M.D. | Cranberry Township | Pennsylvania | 16066 | — |
| Mark Blecher, M.D. | Philadelphia | Pennsylvania | 19148 | — |
| Robert L. Bahr, M.D. | Providence | Rhode Island | 02906 | — |
| Vance Thompson, M.D. | Sioux Falls | South Dakota | 57105 | — |
| Jay Rudd, M.D. | Lacey | Washington | 98503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00747227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00747227 live on ClinicalTrials.gov.